Germline pharmacogenetics of tamoxifen response: have we learned enough?
Desta
Zeruesenay
Z
Flockhart
David A
DA
D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D006801:Humans; D006899:Mixed Function Oxygenases / Q000235:genetics*; D010597:Pharmacogenetics; D013629:Tamoxifen / Q000378:metabolism / Q000627:therapeutic use*
D004965:Estrogen Antagonists; D013629:Tamoxifen; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6